跳至主要内容
临床试验/NCT04220645
NCT04220645已完成不适用

Opportunistic Treatment of Hepatitis C Virus Infection (OPPORTUNI-C): A Pragmatic Clinical Trial of Immediate Versus Outpatient Treatment Initiation Among Hospitalized Patients

University Hospital, Akershus2 个研究点 分布在 1 个国家目标入组 218 人开始时间: 2019年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
218
试验地点
2
主要终点
Treatment completion

研究概览

简要总结

The project will assess the effect of opportunistically treating hepatitis C virus (HCV) infection immediately when HCV-infected people who inject drugs are hospitalized for acute care in psychiatric, interdisciplinary specialized drug treatment or somatic wards. We will compare this approach with the current standard of care (SOC), which is referral to the outpatient clinic at the medical department following discharge.

详细描述

The overall objective is to show that opportunistic and immediate administration of HCV treatment is more efficient compared to referral-based SOC. The specific objectives are: 1) to compare the intervention and SOC groups with regards to treatment completion, treatment uptake and virologic response ; 2) to assess the rate of reinfection after successful HCV treatment; and 3) to assess the frequency of resistant associated substitutions before and after virologic treatment failure.

We will use a stepped wedge design and include patients in 7 clusters

Following randomization of the cluster to the immediate treatment, physicians at the participating wards will be notified in writing that for the next time period patients diagnosed with HCV infection should be treated immediately. In addition, lectures presenting the opportunistic approach will be given and the Department of Microbiology will add a brief text to the result of HCV RNA testing reminding about the opportunistic approach. In the medical and the psychiatric departments, consultants from the departments of infectious diseases or gastroenterology will prescribe immediate treatment. In the departments that provide addiction treatment, local physicians will prescribe treatment. Treatment will be prescribed in accordance with current Norwegian treatment recommendations. The intensity of care after discharge will be individualized at the discretion of the treating physician.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Above 18 years of age
  • HCV RNA positive
  • Inpatient at participating ward
  • Signed informed consent must be obtained and documented according to national and local regulations

排除标准

  • Pregnancy or breastfeeding.
  • In involuntarily health care.
  • Ongoing treatment of hepatitis C.
  • Current participation in another trial that might affect the current study.
  • Any reason why, in the opinion of the investigator, the patient should not participate (e.g. not able to comply with study procedures).

结局指标

主要结局

Treatment completion

时间窗: 12 weeks

Proportion in each arm who have been dispensed the last 28 days package of HCV treatment

次要结局

  • End of treatment response(12 weeks)
  • Sustained virological response(24 weeks)
  • Reinfection(Two years)

研究者

发起方
University Hospital, Akershus
申办方类型
Other
责任方
Principal Investigator
主要研究者

Olav Dalgard

Professor

University Hospital, Akershus

研究点 (2)

Loading locations...

相似试验